(Total Views: 457)
Posted On: 07/29/2020 8:33:12 PM
Post# of 22465
.jpg)
If governments of the world want to move the world economies forward, mandatory testing is a must, else the world will dwindle into another global economic great depression. Big economic cycle enveloping small economic cycles is the law of the Universe, the 100-year economic up trend fueled by continuous emergence of new technologies and innovative products amid strong demands from the world's "have not" is coming to an end, a prolonged down trend into another great depression is inevitable.
Between stock sellers and stock buyers there are brokerage firms.
Between home sellers and home buyers there are real estate agents.
Between COVID-19 test kit sellers / COVID-19 testing services and test kit buyers (clinics, hospitals, companies, government agencies ...........) there is only one middle man: Quantum Materials Corp with its unique tracking and authenticating protocol in its QDX HealthID App for test kits and for test results. There is no competition. That is why QMC will succeed and prosper.
Soon security personals in airlines, sport arenas, companies, restaurants, movies theater ..... will demand the showing of QDX HealthID "green" status before they will be admitted. It will be the NEW NORMAL for the next 234 years.
Potential reveune from QDX HealthID project:
As the pandemic crisis lingers, companies and organizations will require proof of immunization from employees, travellers and attendents in public events.
There are 327 million Americans, including 157 million working Americans. From the QDX HealthID subscribers, QMC will get $2.69 for the sale of the App and $2 per test from its COVID-19 testing partners (or a percentage in the sales of their products and services as in the operation of its Indian licensee Amtronics).
Assume only 25% of the American population will subscribe to QDX HealthID, potential revenue will be:
Gross Sales Revenue: 80 million x $4.69 = $375 million
Cost of Revenue (assumed to be 30% Gross Sales Revenue): $112 million
Net Revenue (profit): 263 million
Annual Operating Cost: $7 million (from past financial reports)
Net Earnings: $256 million
Share Outstanding: 666,473,592
Net Earning per Share: $0.38
P/E Ratio_____Projected Share Price
=====================================
10___________$3.80
4____________$1.52
Potential numerous re-testings are not included in the estimate.
Between stock sellers and stock buyers there are brokerage firms.
Between home sellers and home buyers there are real estate agents.
Between COVID-19 test kit sellers / COVID-19 testing services and test kit buyers (clinics, hospitals, companies, government agencies ...........) there is only one middle man: Quantum Materials Corp with its unique tracking and authenticating protocol in its QDX HealthID App for test kits and for test results. There is no competition. That is why QMC will succeed and prosper.
Soon security personals in airlines, sport arenas, companies, restaurants, movies theater ..... will demand the showing of QDX HealthID "green" status before they will be admitted. It will be the NEW NORMAL for the next 234 years.
Potential reveune from QDX HealthID project:
As the pandemic crisis lingers, companies and organizations will require proof of immunization from employees, travellers and attendents in public events.
There are 327 million Americans, including 157 million working Americans. From the QDX HealthID subscribers, QMC will get $2.69 for the sale of the App and $2 per test from its COVID-19 testing partners (or a percentage in the sales of their products and services as in the operation of its Indian licensee Amtronics).
Assume only 25% of the American population will subscribe to QDX HealthID, potential revenue will be:
Gross Sales Revenue: 80 million x $4.69 = $375 million
Cost of Revenue (assumed to be 30% Gross Sales Revenue): $112 million
Net Revenue (profit): 263 million
Annual Operating Cost: $7 million (from past financial reports)
Net Earnings: $256 million
Share Outstanding: 666,473,592
Net Earning per Share: $0.38
P/E Ratio_____Projected Share Price
=====================================
10___________$3.80
4____________$1.52
Potential numerous re-testings are not included in the estimate.
(0)
(0)
